KLX 171 (Fenofibrate 160 mg)
Pill imprint KLX 171 has been identified as Fenofibrate 160 mg.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 160 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for KLX 171 (Fenofibrate 160 mg)
- 160 mg
- 12.00 mm
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Karalex Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
calcium phosphate dihydrate dibasic
sodium starch glycolate type A potato
Fenofibrate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...